Abstract Submission

Call for Abstracts

The Scientific Committee invites clinicians and scientists, who are interested in sharing their work with the participants of the meeting, to submit their work in abstract form.
Changes in abstracts cannot be made after submission.
Please follow the instructions given below and make sure that each field in the abstract form has been completed.
Abstract submission deadline is May 21, 2023 at 23:59 CEST.

Submit Your Abstract

  • The Scientific Committee invites clinicians and scientists who are interested in sharing their work with the participants of the meeting to submit their work in abstract form.
  • Changes in abstracts cannot be made after submission.
  • Please follow the instructions given below and make sure that each field in the abstract form has been completed.
  • Abstract submission deadline is MAY 21, 2023.
  • Oral communications (sent until MAY 21, 2023) will be published* in the “Journal of Paediatrics and Child Health”.
  • The journal will be available online in a web-based, electronic format.
  • Accepted clinical cases will be presented as poster presentation.
  • The direct link will be published in September, 2023.

* The journal reserves the right to reject abstracts if considered invalid.

 

SUBMIT YOUR ABSTRACT

Topics

  • BDI
    • Neurophysiology and Seizure disorders
    • HIE and Hypothermia
    • Brain imaging
    • Neurodevelopmental outcome of preterm and term infants
    • (Epi-) Genetics/Inborn Errors of Metabolism
    • Basic and Translational Brain Research
    • Brain Research with epidemiological focus
    • Other subjects within the field of perinatal neurology not covered by the above items
  • Circulation/Haematology/Oxygen Transport
    • Near infrared spectroscopy studies
    • Patent ductus arteriosus – diagnosis, treatment and outcome
    • Neonatal haematology and coagulation disorders
    • Cardiovascular outcome of preterm infants and sick term neonates
    • Basic and translational research in the field of neonatal circulation, haematology & oxygen transport
    • Research in the field of cirlulation, haematology & oxygen transport with epidemiological focus
    • Other subjects within the field of perinatal circulation, haematology & oxygen transport not covered by the above item
  • Pulmonology
    • Invasive and non invasive respiratory support, oxygen targeting, respiratory monitoring
    • Basic/translational research in the field of neonatal pulmonology
    • Bronchopulmonary dysplasia – prediction models, diagnosis and treatment
    • Bronchopulmonary dysplasia – long term outcome
    • Apnoea of prematurity – diagnosis, treatment and outcome
    • RSV infection
    • Research in the field of neonatal pulmonology with epidemiological focus
    • Other subjects within the field of neonatal pulmonology not covered by the above items
  • Resuscitation
    • Resuscitation/Golden first hour
    • Perinatal practices/ Fetal therapy
    • Translational research in the neonatal resuscitation/golden hour field
    • Research in the field of neonatal neonatal resuscitation with epidemiological focus
    • Other subjects within the field of neonatal resuscitation not covered by the above items
  • Pharmacology
    • Perinatal pharmacology and anaesthesia
    • Parental drug abuse and effects on the offspring
    • Pain in the NICU: prevention strategies and treatment
    • Translational research in the field of perinatal pharmacology
    • Research in the field of neonatal neonatal pharmacology with epidemiological focus
    • Other subjects within the field of neonatal pharmacology not covered by the above items
  • Epidemiology
    • Epidemiology & Networks
    • Global health
    • Other subjects within the field of neonatal epidemiology not covered by the above items
  • Nutrition
    • Effects of early nutrition therapy on growth, inflammation and metabolism in preterm infants
    • Advantages of human milk/ Human milk banks
    • Discharge nutrition in preterm infants
    • Insulin treatment in neonates
    • Enteral nutrition following intestinal surgery
    • Short bowl syndrome – diagnosis, treatment and outcome
    • Necrotizing enterocolitis – preventive strategies, diagnosis, treatment and outcome
    • Basic/ translational research in the field of neonatal nutrition
    • Research in the field of neonatal neonatal nutrition with epidemiological focus
    • Other subjects within the field of neonatal nutrition not covered by the above items
  • Nursing and Healthcare professionals
    • Nursing
    • Patient safety/Quality improvement methodology
    • Parental stress/ parental involvement
    • Infant family centred and developmental care
    • Research in the field of neonatal neonatal nursing and Infant family centred and developmental care with epidemiological focus
    • Other subjects within the field of neonatal nursing and Infant family centred and developmental care not covered by the above items
  • Four I Section (Infection, Inflammation, Immunology and Immunization)
    • Sepsis/septic shock– diagnosis, treatment and outcome
    • Perinatal CMV infection
    • RSV Infections: prevention and treatment
    • COVID 19
    • Basic/ translational research in the field of neonatal Infection, Inflammation, Immunology and Immunization
    • Research in the field of neonatal Infection, Inflammation, Immunology and Immunization with epidemiological focus
    • Other subjects within the field of neonatal Infection, Inflammation, Immunology and Immunization not covered by the above items

Guidelines

General Overview

We welcome abstracts on all topics of relevance for paediatric research or for clinical practice in neonatology. We will host a programme that includes basic science, epidemiology, clinical investigation, trials, organisation of care, quality improvement, and professional training and education.

Every abstract will be peer-reviewed. The reviewers are appointed by the Executive and Scientific Committees. Please try to fit your abstract into one of the specific topics. This will help us to prepare an interesting conference programme.

We will accept all well-written abstracts that have a general interest regarding the topic in question, the methodology, or the results. In particular, we welcome abstracts reporting on the process of large clinical trials of methodological interest, such as clinical protocols, ethical or organisational issues, pilot data, quality control, or plans for statistical analysis.

The decision on acceptance and the preliminary programme will be made by the scientific committee. Final acceptance and publication on conference materials depends on registration for the conference by one of the authors.

Most of the accepted abstracts will be presented and discussed. There will be three formats:

  • Oral presentation: 10 minutes of presentation and 5 minutes of discussion.
  • Poster presentation: 2 minutes for presentation and 3 minutes for discussion. Presentations will be supported by 2-3 slides + electronic poster.
  • Poster walk: 2 minutes for presentation and 3 minutes for discussion. Presentations will be held in the poster area in front of the poster.
  • Abstracts not accepted for one of the above three formats can be accepted as poster displays – electronic posters with no presentation time.

Abstract Structure

Please note that the abstract needs to be structured, limited to 350 words, and include the following sections:

  1. Background
  2. Methods
  3. Results
  4. Conclusion

1 Table OR 1 image is allowed.

Case reports, limited to 350 words, should include the following sections:

  1. Background
  2. Case report
  3. Conclusion

1 Table OR 1 image is allowed.

Evaluation

Reviewing Process

The scientific committee consists of the ESPR/EBN council, the UENPS council and for the process with assistance from the secretariat.

List of topics

The list of topics for each of the jENS sections + ‘other’ topics to cover new ground is reviewed and revised. Oral parallel sessions are planned for topics where a sufficient number of good abstracts are expected.  Therefore the choice of keynote speakers depends on the list of topics which must be decided before invitations are sent out.

Scoring process

The councils of ESPR/EBN, UENPS always serve as reviewers. The section secretaries expecting many abstracts may engage more people. Each reviewer is expected to review 50 abstracts, and each abstract must be reviewed by at least 3 reviewers. Reviewers must confirm that they will do the reviews in the allocated time period.
The reviewers must score three test abstracts and the statistics is circulated before the abstract submission deadline.
Reviewers score their allotted abstracts (see scoring system below) without knowing the authors or institutions and without knowing the scores of others. Reviewers indicate if they consider the abstract to be less relevant for the topic. Section secretaries oversee the review process of their topics, and the chairman oversees the review of the remaining topics.

When all scores are available

The top-20 scoring abstracts that were submitted by young investigators for the prize, and the top-10 scoring abstracts submitted for the Bengt Roberston prize are re-scored by the scientific committee.

Abstract acceptance and program setting

  1. At the program meeting, one printed copy of each abstract is available. Abstract are on separate sheets of paper and grouped by topics. The meeting program with open abstract slots in the parallel oral sessions and parallel poster sessions is available on the web for simultaneous use during the program meeting.
  2. The committee discusses the lowest scoring abstracts. Abstracts that are of no general interest either regarding question, methodology, or results are rejected.
  3. The abstract for the Bengt Robertson prize is selected.
  4. The six abstracts for the young investigator prize section are selected.
  5. Abstracts indicated as potentially misplaced in topic are moved to other topics if more relevant, or to an ‘open’ group
  6. The Abstracts are distributed into meaningful groups and sequences. The priority is to allow the audience to understand the scientific issues as deeply as possible and to maximise the exchange of experience and views. Since oral parallel sessions generally have a greater audience (fewer parallels), abstracts with broader interest is preferentially used for oral sessions. This work is lead by the section secretaries and the chairman for their respective topics in parallel groups. Some exchange of abstract may take place to optimise the building of meaningful contexts and the abstract from the ‘open’ group is also considered. Abstracts that cannot fit into a context in the program can be rejected at this time as decided by the committee.
  7. When all abstracts for a session has been selected, and the optimal sequence has been determined the paper are clipped together and a session title is coined. Finally, the session title and abstract numbers are typed into the conference program.
  8. Abstract numbers in the program are cross-checked against the abstract data base to make sure that all abstracts have been delt with.
  9. The poster sessions are distributed on the available time slots.
  10. Presenting author names are cross-checked for time conflicts and abstracts or sessions are moved as necessary and possible, or authors are informed.

AFFILIATIONS AND AUTHORS OF THE ABSTRACTS WILL BE ANONYMOUS DURING THE REVIEWING PROCESS

Abstract scores (from 1 to 5; x and COI):

  1. Unintelligible or without general interest as regards either question, methodology, or results, e.g. a case report or case series without a special analysis or interpretation. Why report it?
  2. Studies without a clear question or special analysis or interpretation. Why was done?
  3. Well-motivated experiment, trial, epidemiological investigation, or other observation, but inconclusive by methodological weakness or lack of statistical power. A fair try.
  4. High standard work with firm and well-founded conclusions. A clear hit.
  5. High standard work. Highly relevant: High impact results, or by breaking new ground by question or methodology. A smash!
  6. Clearly interesting, but concerns of major flaw or scientific misconduct. Please fill in comments. Must be discussed by the council.

COI: Conflicts of interest, not evaluated.

Information for presenters

Your abstract can be accepted as poster display, poster walk, poster presentation or oral presentation:

POSTER DISPLAY

All the posters presenters, who received the acceptance email stating that “Your abstract has been accepted as poster display”, should upload an electronic poster as per the instructions below.
Please note there is no presentation for posters.

POSTER WALK

All the poster presenters, who received the acceptance email stating that “Your abstract has been accepted for a poster walk”, are kindly requested to print the poster (requirements will be described in the acceptance email) and check the poster station N° on the final version of the programme on site. The poster walks will take place in the poster area. The *.ppt presentation is not necessary.

POSTER PRESENTATION

All the posters presenters who received the acceptance email stating that “Your abstract has been accepted for a poster presentation” are kindly requested to check the date, time and hall name in the scientific programme.
Poster presenters are requested to upload an electronic version of their abstract as per the instructions below.
The presentation time is 5 minutes in total (2 minutes for presentation and 3 minutes for discussion)
We kindly ask you to prepare a presentation with 2 slides only on a USB key with the following name of the file: “PosterPresentation_lastname_time”. The file should be brought to the slide centre one day before the presentation.
Your presentation will consist of two parts:

  • The poster itself (uploaded as the instructions above)
  • Presentation during a poster session (2 slides – 2 minutes of presentation + 3 minutes of discussion)

ORAL PRESENTATION

All oral presenters are kindly requested to check the date, time and hall name of their presentation in the scientific programme.
The presentation time is 15 minutes in total (10 minutes of presentation and 5 of discussion).
We kindly ask you to prepare a presentation with 5 slides only on a USB key with the following name of the file: “OralPresentation_lastname_time”. The file should be brought to the slide centre one day before the presentation.

Electronic Poster Instructions

After you have been given the link for poster upload, please follow the instruction given below to prepare your electronic poster:
Accepted file format for submission: .PDF
We recommend traditional vertical format (A4).
File size: we suggest max 10 MB

Please consider that the file will be opened with a viewer that fits the scale of the display screen, independently from the screen dimension you have chosen. Therefore, the format is most important than the absolute measure. Different sizes will be anyway visualised, but they cannot appear to fit with the entire display monitor.
The maximum allowed size is 2.160 pixels x 3.840, with a minimum resolution of 72 dpi. The upload is limited to files having 10 Mb maximum, excluding the video files (we suggest A4 format).
One-page posters are the simplest option, but consider that a multipage file is supported. In this case, it is recommended to limit your poster to no more than 3-4 pages.

 

The maximum size for audio files to be uploaded is 10 Mb.

Special Prizes or Contest related to the Abstract Submission

Dedicated to the future of Paediatric research

Young investigators represent the future of Paediatric research. With our dedicated awards, the ESPR seeks to support and honour the outstanding work of our young professionals. 

 

ESPR Early Career Investigator Awards
In honour of Prof Henry Halliday

Requirements

  • applicants must be ESPR members or intending to become members;
  • applicants must be under 36 years of age. A copy of your ID indicating the date of birth is to be submitted along with the CV; applicants >36 years of age, for example due to maternity leave, serious illness or differences in the timeline of their degree, will be considered on an individual bases if content of the abstract relates to work from a primary postgraduate degree (MD/PhD), completed within 2 years of application for the Early Career Investigator Award;
  • applicants will not be considered where the content of the abstract relates to work from postdoctoral research work;
  • the content of the abstract must represent original work and cannot be presented and/or published previously;
  • the name of the presenting author MUST match the name of the applicant.

 

Selected finalists will be informed in advance and have to confirm their attendance of the congress.

 

Bengt Robertson Award
For research concerning the neonatal lung

Requirements

  • Abstracts must be on research concerning the neonatal lung;
  • The content of the abstract must be original work;
  • The applicant must be an ESPR member or intending to become one;
  • Presenting authors must be under 36 years of age. A copy of your ID indicating the date of birth is to be submitted along with the CV; applicants >36 years of age, for example due to maternity leave, serious illness or differences in the timeline of their degree, will be considered on an individual bases if content of the abstract relates to work from a primary postgraduate degree (MD/PhD), completed within 2 years of application for the Bengt Robertson Award;
  • The name of the presenting author MUST match the name of the applicant.

 

The awardee will be informed in advance and has to confirm his/her attendance of the congress.

 

ESPR Travel grants

Requirements

  • You are an Early Career Investigator, as defined by the Early Career Investigators Section of the ESPR. This comprises all healthcare workers working in all specialties in paediatric care (including and not limited to medical students, medical doctors, PhD students, nurses, midwifes) under the age of 46 years at the time of jENS 2023. Applicants should additionally be within 10 years of their PhD defense or end of specialist training.
  • You are an ESPR member or, at the latest, become a member by jENS 2023. To become an ESPR member you have to meet the following requirements:
    • Support the aims of the society;
    • Have given at least one scientific contribution (e.g. presentation or poster) to one of the annual society meetings such as the European Academy of Paediatric Societies Congresses (EAPS) or the Congress of joint European Neonatal Societies (jENS).
  • You are not based within a 300 km radius of Rome.
  • You do not receive other funding to attend jENS 2023.
  • You are not invited to participate at jENS 2023 as a speaker.
  • You have submitted an abstract to jENS 2023 by May 21, 2023. (Medical students who are co-author of an abstract submitted are also eligible to apply, on the condition that they are the presenting author.)

 

Applications for the ESPR Travel Grants will open on the day of the abstract notification for jENS 2023 in the 3rd week of June. Please submit your documents to office@espr.eu.

Application deadline: Monday, 17 July 2023